New technologies and scientific advancements have made it possible for researchers and physicians to tailor treatments to individuals including individualized gene therapies and neoantigen vaccines. HB0192/SB0282 allows patients with life-threatening or severely debilitating illnesses and their physicians to consider these potentially life-restoring immunotherapy treatments after considering all currently FDA approved treatment options. As a pro-vaccine advocate, this is an opportunity to support vaccine innovation and the freedom of Tennesseans to choose the hope of these individualized treatment options. Click the image to take action!